Epinoma Analysis
What is Epinoma?
Epinoma develops epigenetic-driven diagnostics and therapeutics using protein engineering to enhance disease detection and precision medicine.
Product Features & Capabilities
- epigenetic-driven diagnostics, therapeutics, precision epigenetic medicine, disease detection tools, biopharma development insights
Who are the founders of Epinoma
Market Focus
Epinoma primarily focuses on the biotechnology industry, specifically in the areas of epigenetic-driven diagnostics and therapeutics, with an emphasis on disease detection and precision medicine.
Competitors Overview
Epinoma operates in the epigenetic-driven diagnostics and therapeutics market, where it faces competition from several notable companies:
- Lucira Health: Focuses on molecular diagnostics, particularly in infectious diseases. Their advantage lies in rapid testing capabilities, which can be cru
Investors
- Asymmetry Ventures
- Y Combinator
- Gaingels
- LoftyInc Capital Management
- Surf Club Ventures
- Alexander Seyfert
- SeaX Ventures
- seedToB Capital
See something that needs updating? Suggest edits to this profile.